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Asparagine-linked glycosylation is catalysed by oligosac-
charyltransferase (OTase). In Trypanosoma brucei OTase
activity is catalysed by single-subunit enzymes encoded by
three paralogous genes of which TbSTT3B and TbSTT3C
can complement a yeast Dstt3 mutant. The two enzymes
have overlapping but distinct peptide acceptor speciﬁci-
ties, with TbSTT3C displaying an enhanced ability to
glycosylate sites ﬂanked by acidic residues. TbSTT3A
and TbSTT3B, but not TbSTT3C, are transcribed in the
bloodstream and procyclic life cycle stages of T. brucei.
Selective knockdown and analysis of parasite protein
N-glycosylation showed that TbSTT3A selectively transfers
biantennary Man5GlcNAc2 to speciﬁc glycosylation sites
whereas TbSTT3B selectively transfers triantennary
Man9GlcNAc2 to others. Analysis of T. brucei glycosylation
site occupancy showed that TbSTT3A and TbSTT3B glyco-
sylate sites in acidic to neutral and neutral to basic regions
of polypeptide, respectively. This embodiment of distinct
speciﬁcities in single-subunit OTases may have implica-
tions for recombinant glycoprotein engineering. TbSTT3A
and TbSTT3B could be knocked down individually, but not
collectively, in tissue culture. However, both were inde-
pendently essential for parasite growth in mice, suggest-
ing that inhibiting protein N-glycosylation could have
therapeutic potential against trypanosomiasis.
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Introduction
The protozoan parasite Trypanosoma brucei is the causative
agent of human African trypanosomiasis or sleeping sick-
ness. The life cycle of T. brucei includes a bloodstream
(trypomastigote) form in the mammalian host and a procyclic
form in the midgut of the tsetse ﬂy insect vector. In both
forms, the cell surface of T. brucei is covered by a coat of
glycosylphosphatidylinositol-anchored glycoproteins, the
variant surface glycoproteins (VSGs) in the bloodstream
(Cross, 1975) and the procyclins in the insect (Mowatt and
Clayton, 1987; Richardson et al, 1988; Roditi et al, 1989).
These proteins are N-glycosylated, a posttranslational mod-
iﬁcation that modulates folding, stability and activity of
proteins that is essential in most eukaryotes (Varki, 1993;
Sharon and Lis, 1995; Helenius and Aebi, 2004; Ohtsubo and
Marth, 2006). N-glycosylation is catalysed by oligosaccharyl-
transferase (OTase) in the lumen of the endoplasmic reticu-
lum (ER) (Helenius and Aebi, 2004) in which the transfer of
oligosaccharide from a lipid-linked oligosaccharide (LLO)
donor to selected asparagines in the sequons (N–x S/T;
xaP) (Gavel and von Heijne, 1990) of translocated proteins
occurs. Although OTase in higher eukaryotes is a multiprotein
complex of up to eight subunits (Kelleher and Gilmore, 2006),
the genome of T. brucei predicts that it lacks all except for the
catalytic STT3 subunit, for which there are three complete
paralogous genes (Berriman et al, 2005). Some of the addi-
tional subunits of the multiprotein complex OTases increase
the diversity of efﬁciently glycosylated protein substrates.
Ribophorin I (Ost1p) acts as a chaperone to enhance glyco-
sylation of speciﬁc membrane proteins (Wilson and High,
2007), and the oxidoreductase activity of Ost3/6p increase
the glycosylation efﬁciency of deﬁned sequons (Schulz and
Aebi, 2009; Schulz et al, 2009). In mammals, the presence of
either STT3-A or STT3-B in the OTase complex also inﬂuences
glycan substrate speciﬁcity and glycosylation rate, and both
OTase isoforms act sequentially to maximise the efﬁciency of
the N-glycosylation process (Kelleher et al, 2003; Ruiz-
Canada et al, 2009). Although some organisms have extended
the range of OTase activity by adding subunits to the core
catalytic STT3, it is possible that T. brucei has instead
duplicated and diversiﬁed a single-subunit OTase, as seems
to be the case for the related kinetoplastid parasite
Leishmania major (Nasab et al, 2008; Hese et al, 2009).
This hypothesis is supported by the observation that, though
in higher eukaryotes OTase has high speciﬁcity for the mature
Glc3Man9GlcNAc2 glycan, which it transfers to many
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2650different glycosylation sequons, T. brucei selectively transfers
Man5GlcNAc2 to one sequon and Man9GlcNAc2 to another in
the VSG221 protein (Jones et al, 2005; Manthri et al, 2008).
This suggests that a mechanism exists for glycan donor- and
peptide acceptor-speciﬁc glycosylation in this organism,
although the generality of that mechanism beyond VSG has
not been tested.
It has been reported that the single-subunit STT3 OTases
from T. cruzi and L. major can complement an STT3 deletion in
yeast (Castro et al, 2006; Nasab et al, 2008; Hese et al, 2009).
We considered, therefore, that yeast could be a useful ex vivo
model system to investigate the potential substrate speciﬁcities
of the T. brucei OTases and with which to compare the effects
of individual TbSTT3 knockdowns in T. brucei itself.
Results
TbSTT3B and TbSTT3C complement a Dstt3 yeast
mutant with different efﬁciencies and different
acceptor sequon speciﬁcities
There are three putative intact STT3 genes in T. brucei
(TbSTT3A, TbSTT3B and TbSTT3C). Although all three
TbSTT3 proteins were efﬁciently expressed in wild-type
yeast cells at similar levels (Supplementary Figure S1A),
only expression of TbSTT3B and TbSTT3C, but not of
TbSTT3A, could support yeast growth in the absence of
endogenous STT3 (Figure 1A). The Dstt3þTbSTT3B cells
grew almost as well as wild type at 231C, but showed a mild
temperature-sensitive growth phenotype at 371C (Figure 1B);
whereas Dstt3þTbSTT3C cells had a severe growth defect
even at 231C. Owing to the inability of TbSTT3A to support
yeast Dstt3 growth, we determined its function in trypano-
somes by an mRNA silencing approach (see below).
The sequences of TbSTT3B and TbSTT3C share 95%
identity, whereas TbSTT3A share only 79% identity with
them both (Supplementary Figure S2). To investigate whether
the minor sequence differences between TbSTT3B and
TbSTT3C inﬂuence peptide acceptor selection in yeast, we
used a mass spectrometry-based method (Schulz and Aebi,
2009) to analyse the site-speciﬁc glycosylation occupancy of
cell wall proteins in our ex vivo system. We analysed yeast
cells with and without yeast STT3 and with different TbSTT3
genes (Figure 1C; Supplementary Tables SI and SII). Yeast
cells with wild-type OTase and in addition a T. brucei OTase
did not show a reduction in glycosylation at any normally
used site, suggesting that expression of T. brucei OTases did
not interfere with the normal yeast N-glycosylation machin-
ery. In Dstt3þTbSTT3B cells, most sequons were glycosy-
lated with comparable efﬁciency to wild-type yeast, whereas
Dstt3 þ TbSTT3C cells showed lower efﬁciency at more sites,
correlating with the growth phenotypes of these cells
(Figure 1A). Furthermore, TbSTT3B and TbSTT3C did indeed
have different activities towards some glycosylation sequons,
as some sites were more efﬁciently glycosylated by TbSTT3B
and others by TbSTT3C (Figure 1C and D). As for other
OTases (Kasturi et al, 1995; Petrescu et al, 2004) TbSTT3B
and TbSTT3C showed a slight preference for threonine over
serine in the þ2 position of glycosylated sequons
(Figure 1E). Signiﬁcantly, cells expressing TbSTT3B and
TbSTT3C partially glycosylated some sites never used by
yeast OTase (Figure 1C and F) and the occupancy of these
sites was increased in cells lacking yeast OTase activity. This
effect is not solely a result of OTase dosage in cells over-
expressing TbSTT3B or TbSTT3C, as the newly glycosylated
site was different in each case (i.e. N417 of Tos1p by TbSTT3B
and N87 of Ccw14p by TbSTT3C).
We also analysed the sequences surrounding the glycosy-
lated sequons (±5 amino acids) and noticed a tendency
towards efﬁcient occupancy of acidic sequences by
TbSTT3C. These data will be discussed in more detail later.
Only TbSTT3A and TbSTT3B transcripts are found in
bloodstream and procyclic form T. brucei
We used semi-quantitative RT–PCR to assess the relative levels
of the TbSTT3 mRNA transcripts in bloodstream and procyclic
form trypanosomes (Supplementary Figure 1B). We found that
the TbSTT3A and TbSTT3B genes were expressed in both life
cycle stages, with TbSTT3A more highly expressed in the
bloodstream form, whereas transcripts for the TbSTT3C gene
were not detected in either life cycle stage of the parasite.
The TbSTT3A gene encodes a Man5GlcNAc2-speciﬁc
OTase responsible for all paucimannose and complex
N-glycans in T. brucei glycoproteins
We studied the roles of the TbSTT3 genes in trypanosomes
using inducible RNA interference (RNAi) and glycoprotein
structure analysis. Our principal reporter molecule is the VSG
coat glycoprotein of the parasite that, in the variant 221 clone
used in our studies, contains two N-glycosylation sites (see
Figure 2A, inset): one at Asn263 occupied by small, bian-
tennary, endoglycosidase-H (EndoH)-resistant paucimannose
and complex structures, which originate from the transfer of
Man5GlcNAc2 from the Man5GlcNAc2-PP-Dol precursor, and
one at Asn428 occupied by conventional EndoH-sensitive
triantennary oligomannose structures, which originate from
the transfer of Man9GlcNAc2 from Man9GlcNAc2-PP-Dol
(Jones et al, 2005; Manthri et al, 2008). Thus, analysis of
VSG221 N-glycosylation allows us to simultaneously assess
the effects of genetic or chemical perturbations on both
mechanisms of protein N-glycosylation in this organism
(Jones et al, 2005; Urbaniak et al, 2006; Manthri et al,
2008; Stokes et al 2008). Cell-surface VSG can be puriﬁed
in a soluble form (sVSG221) after osmotic shock, a process
that releases VSG from the parasite surface by the action of
endogenous GPI-speciﬁc phospholipase C that cleaves the
dimyristoylglycerol lipid component of the VSG GPI anchor
(Cross, 1975, 1984; Cardoso de Almeida and Turner, 1983;
Ferguson et al, 1985). This cell surface-derived sVSG221 is
amenable to glycoform analysis as an intact glycoprotein by
electrospray–mass spectrometry (ES-MS) and as Pronase
glycopeptides by ES-MS and ES-MS/MS (Jones et al, 2005;
Urbaniak et al, 2006; Manthri et al, 2008; Stokes et al 2008).
In addition, the N-glycosylation status of both cell surface-
derived sVSG221 and of newly synthesised (presumably ER-
associated) VSG221, which is not released by osmotic shock
(Ferguson et al 1986), can be assessed by EndoH and PNGaseF
digestion and analysis by SDS–PAGE and Coomassie blue
staining or anti-VSG221 western blot, respectively.
The three intact TbSTT3 genes are arrayed in tandem on
chromosome 5. One whole TbSTT3A,B,C array was replaced
by homologous recombination with a puromycin acetyl
transferase (PAC) selectable marker to obtain a bloodstream
form TbSTT3A,B,C
þ/  mutant (Supplementary Figure S1C).
This deletion did not affect the glycosylation proﬁle of
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provided us with a heterozygote cell line in which
subsequent selective RNAi knockdowns of TbSTT3s would
be maximised.
A 498 nt internal coding sequence was used to generate a
bloodstream form cell line containing an inducible double-
stranded RNA (dsRNA) construct targeting TbSTT3A in the
TbSTT3A,B,C
þ/  heterozygote (Supplementary Figure S1E).
Tetracycline induction substantially reduced TbSTT3A mRNA
without affecting TbSTT3B mRNA (Figure 3A). The TbSTT3A
knockdown did not have a major effect in the growth of the
parasite in culture (Figure 3B) but it had a clear effect on the
glycosylation of newly synthesised (ER-associated) VSG221.
Thus, the majority of the ER-associated VSG221 in the
TbSTT3A knockdown contained two EndoH-sensitive N-gly-
cans, instead of one EndoH-sensitive and one EndoH-resistant
N-glycan (Figure 3C). Analysis of cell surface-derived
sVSG221 after 72h of RNAi induction showed the presence
of two distinct bands after EndoH digestion, suggesting this
preparation contained two forms of sVSG221 with one and
two EndoH-sensitive N-glycans, respectively, (Figure 3D).
Further analysis of the cell surface-derived sVSG221 by
ES-MS conﬁrmed that two sets of overlapping glycoforms
were present: one set identical to wild-type sVSG221 and
another set with masses compatible with a modiﬁed
sVSG221 with oligomannose structures at both N-glycosyla-
tion sites (Figure 2D; Supplementary Table SIII). This assign-
ment was supported by subsequent Pronase digestion and
ES-MS and ES-MS/MS identiﬁcation of the sVSG221 glycopep-
tides (Supplementary Table SIV; Supplementary Figure S3A).
The apparently greater proportion of modiﬁed versus wild-
type VSG221 in the newly synthesised VSG221 versus mature
cell surface-derived sVSG221 (compare Figure 3C and D)
suggests that the small proportion of wild-type VSG221 pre-
sent in the ER is enriched during ER exit and/or transit to the
cell surface, which is consistent with the apparent importance
of the correct glycosylation of the Asn263 site for VSG221
structure and folding (Blum et al, 1993; Izquierdo et al, 2009).
These data suggest that TbSTT3A is responsible for the
transfer of Man5GlcNAc2 to Asn263 of VSG221 and that, in its
absence, Man9GlcNAc2 is transferred to that site instead via
TbSTT3B. The model described in Manthri et al (2008)
predicts that only sites that receive Man5GlcNAc2 can be
processed to complex structures, because of the absence of
Figure 1 Complementation of yeast Dstt3 by T. brucei OTases. (A) Yeast cells with (STT3) or without (Dstt3) genomic STT3, with the yeast
STT3 gene encoded on a URA3 plasmid (pSTT3), and with various TbSTT3 genes (pTbSTT3A; pTbSTT3B; pTbSTT3C) or with empty vector (p)
on a LEU2 plasmid were grown in serial dilution on minimal media (MM) or media containing 5-FOA for selection of ura-cells and (B) after
selection were grown at different temperatures in serial dilution on MM. (C) Glycosylation occupancy of all sites measured for each strain,
mapped from 100% occupancy, black, to 0% occupancy, white. Values are averages of three independent measurements. Data are shown in
Tables SI and SII. (D) Proportion of threonine in the þ2 position of efﬁciently and poorly glycosylated sequons. (E) Cross correlation of site-
speciﬁc glycosylation efﬁciency by TbSTT3B and TbSTT3C. (F) Glycosylation of TOS1_417 and CCW14_87 sites by T. brucei STT3B and STT3C
that are not used by yeast OTase. Error bars show range.
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Therefore, we also looked at the non-VSG glycoproteins of
the parasite by solubilising parasite ghosts (after osmotic
shock-mediated release of sVSG) and performing SDS–PAGE
and ricin lectin blotting. The terminal galactose-speciﬁc lectin
ricin detects T. brucei glycoproteins expressing complex N-
linked oligosaccharides, including the giant poly-N-acetyllac-
tosamine-containing N-glycans unique to this organism
(Atrih et al, 2005). The striking reduction in ricin binding
to the glycoproteins of the TbSTT3A knockdown cells
(Figure 3E) is in complete agreement with the aforemen-
tioned model and suggests that it is general, rather than
restricted to VSG N-glycosylation.
The TbSTT3B gene encodes a Man9GlcNAc2-speciﬁc
OTase responsible for most or all oligomannose
N-glycans in T. brucei glycoproteins
The same approach was taken to assess the function of
TbSTT3B. A 467 nt internal coding sequence was used to
create a bloodstream form TbSTT3A,B,C
þ/  heterozygote
containing an inducible dsRNA construct targeting both
TbSTT3B and TbSTT3C (Supplementary Figure S1E). As
TbSTT3C mRNA is not present in bloodstream or procyclic
form cells (Supplementary Figure S1B), tetracyline induction
for 72h leads to the selective knockdown of TbSTT3B mRNA
(Figure 4A). As for TbSTT3A, the TbSTT3B knockdown did
not substantially affect the growth of the parasite in culture
(Figure 4B). Analysis of both newly synthesised, ER-asso-
ciated, VSG221 and cell surface-derived sVSG221 after 72h of
TbSTT3B silencing showed the presence of two sets of
VSG221 glycoforms (Figure 4C and D). The lower molecular
weight band co-migrates with wild-type VSG221 treated with
EndoH, suggesting it has only one occupied N-glycosylation
site, whereas the higher molecular weight band has two
EndoH-resistant N-glycans. Analysis of intact and Pronase
digested cell surface-derived sVSG221 after 72h of TbSTT3B
knockdown by mass spectrometry (Figure 2F; Supplementary
Tables SIII, SIV; Supplementary Figure S3B) conﬁrmed the
presence of a lower molecular weight group of sVSG221
glycoforms lacking glycans at Asn428 and a higher molecular
weight group with Asn263 and Asn428 sites occupied by
paucimannose and/or complex glycans, respectively.
These results are also consistent with our model for
VSG221 N-glycosylation (Manthri et al, 2008), such that
removal of TbSTT3B has no effect on the glycosylation of
Asn263 but greatly reduces the efﬁciency of the glycosylation
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Figure 2 Mass spectrometric analyses of intact mature sVSG221 glycoforms before and after selective knockdown of TbSTT3A and TbSTT3B
expression. Samples of sVSG221 from (A) wild type cells, (B) TbSTT3A,B,C
+/ ,( C) TbSTT3A,B,C
+/ -STT3ARNAi minus Tet, (D)
TbSTT3A,B,C
+/ -STT3ARNAi plus Tet, (E) TbSTT3A,B,C
+/ -STT3BRNAi minus Tet and (F) TbSTT3A,B,C
+/ -STT3BRNAi plus Tet were
analysed by ES-MS. The spectra show the masses of the various glycoforms of the intact mature sVSG221 molecules. The inset cartoons
represent our interpretation of those glycoform masses in terms of the ranges of N-glycans present at each of the two N-glycosylation sites.
These assignments combine additional data from the ES-MS and ES-MS/MS analyses of Pronase glycopeptides from the same sVSG221
preparations (Supplementary Figure S3; Table SIV). In the inset cartoons, endo-H-resistant N-glycans are in white and endo-H-sensitive N-
glycans are in black. Circles and squares (ﬁlled and open) represent mannose and N-acetylglucosmaine residues, respectively, and grey circles
represent galactose residues.
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of Man9GlcNAc2 via TbSTT3B). We conﬁrmed the generality
of the results seen with the VSG221 reporter by analysing
the aforementioned non-VSG glycoprotein preparation by
SDS–PAGE and concanavalin A (ConA) blotting (Figure 4E).
ConA binds with highest afﬁnity to oligomannose and hybrid
glycans containing a Mana1-3(Mana1-6)Mana1-motif and
less well to complex biantennary-type structures (Brewer
and Bhattacharyya, 1986). Thus, the signiﬁcant reduction in
ConA binding to the glycoproteins from the TbSTT3B knock-
down cells suggests that most or all of the conventional
triantennary oligomannose N-linked glycans have disap-
peared in parallel with TbSTT3B knockdown.
TbSTT3A and TbSTT3B have distinct acceptor sequon
speciﬁcities as well as oligosaccharide donor
speciﬁcities
To establish if there are consensus sequences or patterns
that control site-speciﬁc N-glycosylation by TbSTT3A or
TbSTT3B, we developed a mass spectrometry approach to
analyse wild-type bloodstream form T. brucei glycoproteins,
summarised in ‘Materials and methods’ and in Supple-
mentary Figure S4. Brieﬂy, the glycoproteins were captured
from VSG-depleted trypanosome lysates by sequential afﬁnity
chromatography on immobilised ricin followed by immobi-
lised ConA. The ricin- and ConA-binding fractions were
eluted with appropriate sugars and individually processed
by digestion with endoH followed by PNGaseF. Thus,
endoH-sensitive glycopeptides appear 203Da heavier by
mass spectrometry because of the GlcNAc residue left
attached to the relevant Asn residues by endoH whereas the
remaining endoH-resistant, but PNGaseF-sensitive, sites ap-
pear 1Da heavier by mass spectrometry because of the
conversion of the relevant Asn residues to Asp by PNGaseF.
Using this method, we noticed that many of the amino-acid
sequences immediately adjacent to the sequons presenting
complex or paucimannose N-glycans contained aspartic and/
or glutamic acid residues, suggesting that charge might have
a function in sequon recognition by TbSTT3A. To test this
hypothesis, the isoelectric points (pIs) of the sequons them-
selves, plus ﬁve residues N- and C-terminal to them, were
calculated. The exclusively EndoH-resistant sites, that is
those modiﬁed by TbSTT3A, tend to be found within more
acidic regions of protein sequence (mean±s.d. pI of
4.8±1.7) whereas the exclusively EndoH-sensitive sites,
that is those modiﬁed by TbSTT3B, tend to be within neutral
to basic regions (mean±s.d. pI of 9.5±2.2). The mixed sites,
that is those that have been partly modiﬁed by TbSTT3A and
partly by TbSTT3B, are relatively evenly spread between
these pI extremes (Figure 5; Supplementary Tables SV and
SVI). Therefore, the different polypeptide acceptor substrate
speciﬁcities of TbSTT3A and TbSTTB seem to be, at least in
part, related to the pIs of the peptide sequences immediately
around the N-glycosylation sites.
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Figure 3 The effects of RNAi silencing of STT3A on protein glycosylation in T. brucei. (A) Northern blot of total RNA extracted from the
following cell lines: wild type (lane 1), TbSTT3A,B,C
þ/  (lane 2), TbSTT3A,B,C
þ/ -STT3ARNAi minus Tet (lane 3), TbSTT3A,B,C
þ/ -
STT3ARNAi plus Tet (lane 4), TbSTT3A,B,C
þ/ -STT3BRNAi minus Tet (lane 5) and TbSTT3A,B,C
þ/ -STT3BRNAi plus Tet (lane 6) were
probed with the STT3A probe (upper panel) and stained with ethidium bromide for rRNA as loading control (lower panel). (B) Growth of the
following T. brucei cells at 371C: wild type (closed circles), TbSTT3A,B,C
þ/ -STT3ARNAi minus Tet (open squares) and TbSTT3A,B,C
þ/ -
STT3ARNAi plus Tet (closed triangles). (C) Cell ghosts containing ER-associated VSG221 and (D) cell surface-derived sVSG221 from the
following cells: TbSTT3A,B,C
þ/  (lanes 1–3), TbSTT3A,B,C
þ/ -STT3ARNAi plus Tet (lanes 4–6) and TbSTT3A,B,C
þ/ -STT3ARNAi minus Tet
(lanes 7–9) were digested or not, as indicated, with EndoH or PNGaseF were subjected SDS–PAGE and either western blot with anti-VSG221
antibody (C) or staining with Coomassie blue (D). The cartoons above the gels in panels (C) and (D) summarise the types of VSG221 present
with respect to EndoH-resistant biantennary paucimannose and complex N-glycans (grey) and EndoH-sensitive triantennary oligomannose N-
glycans (black). (E) Blots of total glycoprotein extracts of the following cells: wild type (lane 1), TbSTT3A,B,C
þ/  (lane 2), TbSTT3A,B,C
þ/ -
STT3ARNAi minus Tet (lane 3) and TbSTT3A,B,C
þ/ -STT3ARNAi plus Tet (lane 4) were incubated with ricin without (upper panel) and with
carbohydrate inhibitors (speciﬁcity control, middle panel) or stained with Pounceau red (loading control, lower panel).
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preference for acidic acceptor sequences to TbSTT3A
expressed in T. brucei
As mentioned earlier, we cannot make a direct comparison
between the speciﬁcities of TbSTT3A and TbSTT3C because
TbSTT3A does not complement Dstt3 yeast and TbSTTC is not
expressed in trypanosomes. However, in T. brucei, sites receiv-
ing endoH-resistant paucimannose/complex glycans through
TbSTT3A are relatively acidic and the same is true of sites
exhibiting high glycosylation efﬁciency in Dstt3þTbSTT3C
yeast cells (Supplementary Table S1). This is apparent from
the data plotted in (Figure 6). Figure 6A shows the distribu-
tions of pIs of the acceptor sequons (±5 amino acids) for sites
recognised principally by TbSTT3A (endoH-resistant sites),
principally by TbSTT3B (endoH-sensitive sites) and by both
(mixed sensitivity sites) in T. brucei. Figure 6B and C show the
comparable distributions of pIs for sites that are efﬁciently
(480%), poorly (o20%) and moderately (20–80%) glycosy-
lated in Dstt3þTbSTT3C and Dstt3þTbSTT3B yeast cells,
respectively. These data illustrate the similar preferences of
TbSTT3C and TbSTT3A for acidic sites, and the lack of any
obvious preference of TbSTT3B when it is expressed in either
Dstt3 yeast or in T. brucei.
Both TbSTT3A and TbSTT3B catalysed N-glycosylation
mechanisms are essential for infectivity in mice
Both N-glycosylation mechanisms are, individually, non-
essential for parasite growth in culture (Figures 3B and 4B).
However, we found that simultaneous knockdown of TbSTT3A
and TbSTT3B halted the growth of bloodstream form trypano-
somes in culture (Supplementary Figure S1F), showing that
protein N-glycosylation per se is essential in culture.
We next investigated whether the TbSTT3A/TbSTT3B
redundancy seen in culture was also evident in animal
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Figure 5 Distribution of the type of N-glycan occupancy related to
the isoelectric point (pI) of the acceptor site peptide. The predicted
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cline-free mice, the infections in the presence of RNAi-inducing
doxycycline were very low in both cases (Figure 7A and B).
Western blot analysis of the VSG221 from the few surviving
cells showed that they were expressing signiﬁcant amounts of
wild-type N-glycosylated VSG221 (Figure 7C and D). Most
likely these cells proliferated because they had lost some of
the effects of the doxycycline-induced TbSTT3 knockdown, a
well-known phenomenon in T. brucei RNAi experiments. These
data suggest that both mechanisms of protein N-glycosylation
are independently required for parasite growth in mice.
Discussion
In common with the related kinetoplastids T. cruzi and
L. major (Ivens et al, 2005), and with the unrelated protist
Giardia lamblia (Morrison et al, 2007), the genome of
T. brucei lacks identiﬁable homologues of all known OTase
subunits except for the catalytic subunit, STT3, for which it
has three intact genes, TbSTT3A,B and C (Berriman et al,
2005; Kelleher and Gilmore 2006). The goal of this work was
to elucidate the speciﬁcities and roles of the three TbSTT3
proteins in T. brucei.
Although we cannot formally exclude the possibility that
heterologous expression of TbSTT3s in yeast might affect
their speciﬁcities, or that STT3 protein levels necessarily
correlate directly with enzymatic activity, the heterologous
complementation of Stt3p mutant yeast strains with STT3
proteins from protozoan organisms seems, thus far, to be a
good experimental system to study STT3 function and speci-
ﬁcity (Shams-Eldin et al, 2005; Castro et al, 2006; Nasab et al,
2008; Hese et al, 2009). Studies on the four STT3 genes of
L.major showed that three of them complement the yeast
Δstt3 yeast + TbSTT3C 
Glycosylation efficiency
Isoelectric point
4 6 8 10 12
Isoelectric point
468 1 0 1 2
T. brucei  
N-glycan EndoH sensitivity
Isoelectric point
4
R
M
S
E
M
P
E
M
P
6 8 10 12
Δstt3 yeast + TbSTT3B 
Glycosylation efficiency
Figure 6 Correlations of N-glycan type in T. brucei and N-glycosylation efﬁciency in Dstt3 yeast with acceptor site pI. (A) Box plot
(Tukey, 1977) of predicted pI distributions for the sequons ±5 amino acids occupied by endoH-resistant (R), mixed (M) or endoH-sensitive
(S) N-glycans. (B, C) Box plots of predicted pI distributions for the sequons ± 5 amino acids exhibiting efﬁcient (E), moderate (M) and poor
(P) N-glycosylation in Dstt3 þTbSTT3C and TbSTT3B yeast cells, respectively. Note: Box plots are concise ways of illustrating a distribution of
values. The black line shows the median, the box encompasses 50% of the data, the whiskers, 75% of the data and the outliers are shown as
discrete points.
–Dox +Dox –Dox +Dox
+
51 kDa
–
–
EndoH
PNGaseF
+
–
–
+
–
–
+
–
–
+
–
–
+
–
–
+
123 456789
WT TbSTT3A RNAi 
+Dox –Dox
Cell surface-derived VSG
51 kDa
–
–
EndoH
PNGaseF
+
–
–
+
–
–
+
–
–
+
–
–
+
–
–
+
1234567 89
WT TbSTT3B RNAi
+Dox –Dox
Cell surface-derived VSG
+
+
T
r
y
p
s
 
p
e
r
 
m
l
 
b
l
o
o
d
T
r
y
p
s
 
p
e
r
 
m
l
 
b
l
o
o
d
8E8
6E8
4E8
2E8
0E8
6E8
4E8
2E8
0E8
Figure 7 Animal infectivity studies with STT3ARNAi and STT3BRNAi cell lines. (A)T . brucei TbSTT3A,B,C
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before and throughout the 3 day infection. (C) Puriﬁed sVSG221 of wild-type cells grown in culture (lanes 1–3, as a control), and
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not, as indicated, with EndoH or PNGaseF were subjected SDS–PAGE and western blot with anti-VSG221 antibody.
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tion without association with other yeast OTase subunits
(Nasab et al, 2008; Hese et al, 2009) and that they have
overlapping but distinct peptide substrate speciﬁcities (Nasab
et al, 2008; Hese et al, 2009). Similar ex vivo studies carried
out here showed that TbSTT3B and TbSTT3C are functional
single-subunit OTases able to rescue the yeast DStt3 mutant.
Furthermore, the glycosylation site occupancy data high-
lighted the different polypeptide acceptor speciﬁcities of
TbSTT3B and TbSTT3C and, in particular, a preference for
TbSTT3C (which rescued the yeast Dstt3 mutant at the
expense of a severe growth phenotype) for acceptor sequons
in relatively acidic local environments. Despite these suc-
cesses, the ex vivo approach provided no information on
TbSTT3A because its acceptor and/or donor speciﬁcity is/
are incompatible with the growth of Saccharomyces cerevi-
siae. To address this issue, we studied the expression of the
TbSTT3 genes in the bloodstream and procyclic form T. brucei
and the functions of the two expressed genes (TbSTT3A and
TbSTT3B) in bloodstream form trypanosomes using induci-
ble RNAi knockdown in bloodstream form parasites.
TbSTT3A is more highly expressed in bloodstream form
than procyclic form T. brucei and its selective knockdown
produced a profound glycosylation phenotype in bloodstream
form parasites that show that TbSTT3A is largely or solely
responsible for the transfer of the biantennary Man5GlcNAc2
precursor during the biosynthesis of glycoproteins in the ER
of T. brucei. The data also conﬁrmed that the processing of
biantennary Man5GlcNAc2 attached to protein is the only
route to complex N-glycans in this organism (Manthri et al,
2008). In contrast, TbSTT3B is highly expressed in both life
cycle stages and its selective knockdown in bloodstream form
parasites showed that TbSTT3B is largely or solely respon-
sible for the transfer of the triantennary Man9GlcNAc2
precursor during the biosynthesis of glycoproteins in the ER
of T. brucei and conﬁrmed that the processing of triantennary
Man9GlcNAc2 attached to protein is the only route to
oligomannose N-glycans in this organism (Manthri et al,
2008). As noted earlier (Manthri et al, 2008), the strict
demarcation between these different routes to complex and
oligomannose N-glycans seems to be due to the absence of
the Golgi mannosidase II activity that permits the conversion
of triantennary Man5GlcNAc2 to Man3GlcNAc2 in other
eukaryotes.
This clear selectivity for different LLO donors by TbSTT3A
and TbSTT3B is novel. Mammalian and yeast OTase com-
plexes, which operate in organisms with full repertoires of
the ALG genes responsible for LLO biosynthesis, are selective
for Glc3Man9GlcNAc2-PP-Dol whereas protists and fungi that
lack groups of ALG genes (Samuelson et al, 2005) display
either little speciﬁcity for donor LLO structure or are tuned to
selectively transfer the end LLO product of their modiﬁed
dolichol cycles (Kelleher et al, 2007). In the case of T. brucei,
the end product of LLO synthesis is Man9GlcNAc2-PP-Dol and
TbSTT3B does indeed have a preference for this donor
whereas TbSTT3A has speciﬁcity for the ﬁrst topologically
competent LLO intermediate Man5GlcNAc2-PP-Dol.
The two OTases also differ substantially in apparent pep-
tide acceptor substrate speciﬁcity, with TbSTT3A showing
unusual selectivity for glycosylation sequons ﬂanked by
acidic residues. TbSTT3C also showed a similar preference
for acidic sites; however, it is difﬁcult to compare TbSTT3A
and TbSTT3C because the two could not be studied in the
same organism. Nevertheless, it is tempting to speculate that
TbSTT3C (which is more closely related to TbSTT3B) might
have hybrid properties, perhaps sharing the features of the
acidic peptide acceptor speciﬁcity of TbSTT3A with the more
conventional Man9GlcNAc2-PP-Dol LLO donor speciﬁcity of
TbSTT3B. It may be that TbSTT3C is expressed at speciﬁc
parasite life cycle stage(s) when the organism might require
oligomannose structures attached to relatively acidic glyco-
sylation sites. In this respect, it is worth noting that the cell-
surface BARP glycoproteins, which are speciﬁcally expressed
in the epimastigote form of the parasite in the tsetse salivary
glands (Urwyler et al, 2007), present one or two relatively
acidic N-glycosylation sites per molecule.
Analysis of VSG glycosylation in the TbSTT3A RNAi
knockdown shows that, in the absence of TbSTT3A,
TbSTT3B is able to transfer Man9GlcNAc2 to the acidic
Asn263 site rather efﬁciently, such that most of the VSG in
the ER contains Man9GlcNAc2 at both Asn263 and Asn428
(Figure 4C). This is consistent with our model that TbSTT3A
rapidly modiﬁes acidic sites, possibly in a co-translational
fashion, whereas TbSTT3B subsequently glycosylates any
remaining sites, regardless of pI. In other words, TbSTT3A
has distinct acceptor peptide substrate speciﬁcity, whereas
TbSTT3B has very broad speciﬁcity. The latter is also borne
out by the yeast data in Figure 1. This helps to explain why in
the procyclic form of the parasite, which expresses predomi-
nantly TbSTT3B, the relatively acidic N-glycosylation sites of
the procyclins are occupied by triantennary oligomannose
Man5GlcNAc2 glycans (Treumann et al, 1997) and why the
lysosomal glycoprotein p67 contains complex N-glycans in
the bloodstream form of the parasite but exclusively oligo-
mannose structures in the procyclic form (Kelley et al, 1995.
It is interesting to note that, though in the TbSTT3A
knockdown the ER resident VSG is predominantly modiﬁed
with oligomannose glycans at both Asn263 and Asn428, the
mature cell-surface VSG is made up of these mutant VSG
glycoforms plus wild-type VSG glycoforms (Figures 3D and
4D). Presumably, the incomplete knockdown of TbSTT3A
mRNA allows some wild-type VSG to be synthesised and this
is enriched during the process of ER exit and/or transit to the
cell surface. It is possible that incorrect glycosylation of the
Asn263 site might destabilise VSG221 and lead to its degrada-
tion. This site seems to be particularly important in VSG221
because the wild-type paucimannose and small complex
N-glycans at Asn263 occupy the same space as a short
a-helix of peptide in other VSG variants (Blum et al, 1993)
and because this site seems to interact selectively with the
calreticulin/UDP-glucose:glycoprotein glucosyltransferase
protein folding/quality control system (Izquierdo et al, 2009).
Analysis of the VSG molecules in the TbSTT3B RNAi
knockdown shows that, in the absence of TbSTT3B,
TbSTT3A barely modiﬁes Asn428 at all (Figures 3F, 4C and
D) and, when it does, it transfers exclusively Man5GlcNAc2,
leading to the synthesis of complex glycans at this site. The
underglycosylation of Asn428 in the TbSTT3B knockdown is
more severe than that seen in the TbALG3 null mutant, which
has normal levels of TbSTT3A and TbSTT3B but can only
make Man5GlcNAc2-PP-Dol (Manthri et al, 2008). This in-
dicates that TbSTT3B that normally uses Man9GlcNAc2-PP-
Dol can in its absence use Man5GlcNAc2-PP-Dol, albeit
relatively inefﬁciently, to glycosylate Asn428.
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has strict speciﬁcity for the Man5GlcNAc2-PP-Dol LLO donor
and is highly selective for acidic peptide acceptor sites. (ii)
TbSTT3B is selective, but not speciﬁc, for the Man9GlcNAc2-
PP-Dol LLO donor and has broad speciﬁcity for peptide
acceptor sites. (iii) TbSTT3C can use Glc3Man9GlcNAc2-
PP-Dol donor and has more selectivity for acidic peptide
acceptors than TbSTT3B. Although we conclude that
local pI around the glycosylation sequon correlates with
sequon usage by the different TbSTT3s, we acknowledge
that other factors, such as position in the polypeptide
and, thus, local secondary and tertiary structure are also
likely to have signiﬁcant functions in differential N-glycosyl-
ation in T. brucei. These aspects are currently under
investigation.
Some subunits of the multiprotein complex OTase of higher
eukaryotes tune protein- or site-speciﬁc N-glycosylation ac-
tivity (Wilson and High, 2007; Ruiz-Canada et al, 2009;
Schulz et al, 2009). This additional control or regulation of
OTase activity possibly arises from an evolutionary advantage
in some organisms for increased diversity of glycosylation
sites. Although higher eukaryotes may have achieved this by
the addition of proteins to the OTase complex, the data
presented here support the hypothesis that gene duplication
and diversiﬁcation of STT3 activity and speciﬁcity have
occurred in T. brucei. Regardless of the reason, the dual N-
glycosylation mechanism used by T. brucei produces an
extraordinarily high N-glycosylation efﬁciency, with 96% of
all sites occupied as compared to B50–60% for other eukar-
yotes (Petrescu et al, 2004). It is remarkable that minor
differences in amino-acid sequence, especially between
TbSTT3B and TbSTT3C, lead to substantial alterations in
their polypeptide acceptor substrate speciﬁcities
(Supplementary Figure S2). The WWDYG motif and the
surrounding amino-acid sequences are totally conserved in
the three proteins, whereas the residues in and near the DxxK
motif (Igura et al, 2008) present more variability. The novel
LLO donor and acceptor peptide speciﬁcities of the T. brucei
STT3 proteins certainly raise possibilities for their usage in
glycoprotein engineering in heterologous systems.
The exact reason(s) why T. brucei has evolved parallel
and selective routes to oligomannose and complex glycan
synthesis is not clear. However, it could have occurred to
compensate for T. brucei’s apparent loss of Golgi mannosi-
dase II genes (which disallows complex glycan formation)
and/or to provide a ‘fast-track’ to paucimannose/complex
glycan synthesis from Man5GlcNAc2-PP-Dol. The latter might
provide a selective advantage when one considers that about
50% of the N-glycosylation sites across all of its
highly abundant VSG molecules are paucimannose or com-
plex (Mehlert et al, 1998). Thus, fast tracking would mini-
mise the drain on Dol-P-Man donors (necessary for
converting Man5GlcNAc2-PP-Dol to Man9GlcNAc2-Dol) that
are also required for GPI anchor biosynthesis, which is
prodigious in this organism because it makes and turns
over a 10-fold excess of GPI precursors (Ralton et al, 1993).
Thus, overall, one might speculate that the unusual physiol-
ogy of this protozoan parasite, which must synthesise an
entire contiguous coat of protective surface glycoprotein
to survive, may have provided the evolutionary pressure
for N-glycosylation acceptor sites and OTase speciﬁcities
to co-evolve.
Finally, it is surprising that the separate knockdown of
TbSTT3A and TbSTT3B, with consequent disappearance of
most paucimannose/complex or oligomannose N-glycans,
respectively, from all glycoproteins in the parasite can be
tolerated in culture, with only a marginal growth phenotype
in both cases. On the other hand, both STT3 activities are
independently essential in a mouse infection model. This
result emphasises that gene functionality should be tested
in vivo, that is in an animal model of infection, before making
ﬁnal conclusions about gene essentiality. The essentiality of
both TbSTT3A and TbSTT3B in vivo and their novel speciﬁ-
cities (particularly that of TbSTT3A) may offer potential
therapeutic targets for future exploitation.
Materials and methods
TbSTT3 plasmid constructs
Each of the three TbSTT3 ORFs were ampliﬁed from genomic DNA
by PCR and cloned into a pGEM vector; and into a pBAD Escherichia
coli expression vector, introducing a C-terminal myc-His6 tag; and
then into a pRS425_GPD_CYC1 yeast expression vector (pTbSTT3A,
pTbSTT3B and pTbSTT3C).
Yeast manipulation
Yeast strains used were Y24390 (EUROSCARF, Frankfurt, Germany),
YBS1 (Mat@ his3D1 leu2D0 lys2D0 met15D0 ura3D0
Dstt3HkanMX4 pSTT3), YBS2 (Mat@ his3D1 leu2D0 lys2D0
met15D0 ura3D0 Dstt3HkanMX4 pTbSTT3B) and YBS3 (Mat@
his3D1 leu2D0 lys2D0 met15D0 ura3D0 Dstt3HkanMX4 pTbSTT3C)
(Nasab et al, 2008). Cells were grown at permissive temperature in
YPD; for maintaining plasmids, in minimal medium; for selection of
kanMX4 carrying strains with 100mg/ml G418; or for selection of
ura-cells with 5-ﬂuoroorotic acid (5-FOA) (Boeke et al, 1987) and
1M sorbitol. Haploid cells with genomic deletion of STT3 and
expressing a TbSTT3 were created essentially as described (Castro
et al, 2006), but using pSTT3 (Zufferey et al, 1995) containing the
yeast STT3 locus in a URA3 YEp352 vector. Addition of 5-FOA to the
media allowed for selection of cells that had lost the URA plasmid
encoding the wild-type yeast STT3. These cells could only survive if
expression of a plasmid-borne T. brucei STT3 paralogue comple-
mented the lack of yeast STT3.
Site-speciﬁc glycosylation occupancy determination
Proteins covalently linked to the cell wall polysaccharide matrix
were prepared from yeast cells, detected with liquid chromatogra-
phy–electrospray ionisation–tandem mass spectrometry (LC-ES-
MS/MS), and analysed as described earlier (Schulz and Aebi, 2009).
Glycosylation sites with more than 95% occupancy were deﬁned as
being ‘efﬁciently’ glycosylated.
Cultivation of trypanosomes
Bloodstream form T. brucei genetically modiﬁed to express T7
polymerase and the tetracycline repressor protein were cultivated in
HMI-9 medium as described in Wirtz et al (1999).
Generation of constructs and transfomation of bloodstream
form T. brucei
530-bp 50- and 406-bp 30-UTR sequences were PCR ampliﬁed from
genomic DNA using HiFi Taq Platinum with 50-atgCGGCCGcgaac
ggatggcagtcatttgc-30 and 50-gtttaaacttacggaccgtcaagcttgtacgtataa
ggagggg-30 and 50-gacggtccgtaagtttaaacggatccgttatgctgttgttaggg-30
and 50-ataagtaaGCGGCCGCaatacgcaacctccacaagc-30 as forward and
reverse primers, respectively. The two PCR products were used
together in a further PCR reaction to yield a product containing the
50-UTR linked to the 30-UTR by a short HindIII and BamHI cloning
site (underlined) and SalI and NotI restriction sites at each end
(capital letters). The PCR product was cloned into the SalI and NotI
sites of the pGEM-5Zf(þ) vector (Promega) and the PAC drug
resistance gene, with exogenous T7 promoter and terminator
sequences, was introduced into the targeting vector through the
HindIII and BamHI sites. For RNAi internal coding sequences
were PCR ampliﬁed from genomic DNA using HIFI Taq
Platinum with 50-cgcGGATCCccctctttgggggtgc-30 and 50-ccgCTCGAG
The single-subunit OTases from Trypanosoma brucei
L Izquierdo et al
The EMBO Journal VOL 28 | NO 17 | 2009 &2009 European Molecular Biology Organization 2658attgggtagatcagtcacg -30 (BamHI and XhoI sites, respectively, in
capital letters) for Tb927.5.890 (TbSTT3A), and 50-cgcGGATCCgat-
gatttctttggttacc -30 and 50-ccgCTCGAGctcagaatatatccggaa -30 (BamHI
and XhoI sites, respectively, in capital letters) for Tb927.5.900
(TbSTT3B). The 498 nt (TbSTT3A) and 467 nt (TbSTT3A) internal
coding sequences were cloned into p2T7TA (Alibu et al, 2005), cut
with BamHI and XhoI, to generate p2T7-STT3A and p2T7-STT3B.
These plasmids were then digested with NotI, and puriﬁed for
transfection. Finally, for RNAi of TbSTT3A/B/C a 493 nt internal
coding sequence was PCR ampliﬁed from genomic DNA using HIFI
Taq Platinum with 50-cgcGGATCCgtagccattcatcgtgtgc -30 and 50-
ccgCTCGAGggta
cgcaaatcgcaagg -30 (BamHI and XhoI sites, respectively, in capital
letters) and cloned into p2T7TA, to generate p2T7-TbSTT3All.
These plasmids were then digested with NotI, precipitated and
washed in 70% ethanol, dissolved in sterile distilled water, and
used for T. brucei transformation (Wirtz et al, 1999).
Northern blotting
Total RNA for Northern blots was prepared using Qiagen RNeasy Midi
kits. Samples of RNA (5mg) were run on formaldehyde–agarose gels
and transferred to Hybond N nylon membrane (Amersham Bios-
ciences) for hybridisation with [a-32P] dCTP-labeled T. brucei
Tb927.5.890 or Tb927.5.900 probe (Amersham Rediprime II).
Small-scale soluble-form VSG isolation
Soluble-form VSG (sVSG) was isolated from 100ml cultures
containing B2 10
8 bloodstream form T. brucei as described in
Cross (1984).
ES-MS analysis of intact and Pronase digested VSG
Samples of the sVSG preparations were diluted to B0.07mg/mli n
50% acetonitrile, 1% formic acid, loaded into nanotips (Micromass
type F), and analysed by positive ion ES-MS on a Q-Star XL
instrument (Applied Biosystems). Data were collected and pro-
cessed using the Bayesian protein reconstruction algorithm of
Analyst software. Samples of sVSG were digested with Pronase and
the resulting glycopeptides enriched and analysed by ES-MS and ES-
MS/MS as described in Manthri et al (2008).
ER–VSG SDS–PAGE and western blotting
sVSG-depleted T. brucei ghosts (Bohme and Cross, 2002), equivalent
to B2 10
5 cells were subjected to SDS–PAGE and transferred to
polyvinylidene diﬂuoride Hybond-P membranes (Amersham Bios-
ciences). The membranes were incubated for 1h with anti-VSG221
rabbit polyclonal antibody diluted 1:4000 in PBS and then 1h with
anti-rabbit conjugated to horseradish peroxidase diluted 1:10000 with
the same buffer. Membranes were developed with ECL (Amersham
Biosciences) according to the manufacturer’s instructions.
Lectin blotting of T. brucei cell extracts
Bloodstream form T. brucei cells were washed twice in trypanosome
dilution buffer, solubilised with 2% SDS and 4M urea, subjected to
SDS–PAGE and transferred to nitrocellulose membranes (Amersham
Biosciences). The membranes were incubated for 1h with biotin-
conjugated ricin (Vector Labs) diluted 1/3000, with or without
inhibitors (10mg/ml galactose and 10mg/ml lactose) or 1h with
ConA (Sigma) diluted 1/3000, with or without inhibitor (0.5M a-
methyl mannose). Then, membranes were incubated for 1h with
extravidin-HRP diluted 1/10000, and developed with ECL (Amer-
sham Biosciences) according to the manufacturer’s instructions.
Mouse infection studies
The RNAi inducible cells were subcultured and grown without
selection drugs for 48h with and without 1mg/ml tetracycline. The
parasites were then introduced into groups of ﬁve mice (dosed with
and without doxycycline, respectively) by intraperitoneal injection of
3 10
5 parasites. The plus doxycycline group of animals were dosed
with doxycycline in the drinking water (0.2mg/ml in a 5% sucrose
solution) for 1 week before infection and until the experiment was
terminated. Infections were assessed by tail bleeding and cell counting.
Extraction of ricin and ConA-binding glycoproteins
Bloodstream form T. brucei, were isolated from infected rats,
puriﬁed over DEAE-cellulose and subjected to hypotonic lysis to
release cytosolic components as well as the majority
of the VSG coat as sVSG (Cross, 1984). The cell ghost pellets (10
11
cell equivalents) were solubilised in 50ml of 8M urea, 3% SDS,
50mM Tris–HCl, pH 6.8. The SDS/urea extract was diluted 50 times
in buffer A (50mM Tris–HCl, pH 6.8, 400mM NaCl, and 0.8%
Triton X-100, 0.1mM TLCK, 1mg/ml leupeptin and 0.1% sodium
azide). Ricin-coupled agarose (Vector Laboratories, 4-ml packed
volume) was added to the suspension, rotated gently overnight at
41C, recovered by gentle centrifugation and packed into a
5cm 1cm column. The column was washed with 5 volumes of
buffer A and bound material was eluted with 30mg/ml lactose and
30mg/ml galactose in 4-fold diluted buffer A. ConA-coupled
Agarose (Vector Laboratories) was added to the recovered super-
natant from the earlier pull-down with Ricin–Agarose adjusted
earlier to 150mM NaCl, 5mM CaCl2, 5mM MnCl2 and 1mM MgCl2,
and recovered by gentle centrifugation and packed into a
5cm 1cm column. Bound material was eluted with 0.5M
methyl-alpha-D-mannopyranoside in 4-fold diluted Buffer A.
Sequential endoglycosidase digestion of eluted glycoproteins
and mass spectrometry analysis
Aliquots of the eluted Ricin-bound and ConA-bound fractions were
independently subjected to EndoH followed by PNGaseF digestion
(Roche Applied Science), subjected to SDS–PAGE and the gel lanes
were then divided into 10 independent slices. Proteins in each slice
were excised, reduced and alkylated, by the addition of 10mM DTT
and then 50mM iodoacetamide. The samples were digested with
25ml of 12.5mg/ml modiﬁed trypsin (Roche Applied Science) in
20mM ammonium bicarbonate. An aliquot of the tryptic digest
(recovered in 1% formic acid in water) was analysed by LC-MS on
an LTQ-Orbitrap mass spectrometer (ThermoElectron) coupled to a
Dionex 3000 nano-LC system. The Orbitrap was set to analyse the
survey scans at 60000 resolution and the top ﬁve ions in each duty
cycle selected for MS/MS in the LTQ linear ion trap. The raw ﬁles
were processed to generate a Mascot generic ﬁle using the program
Raw2msm and searched against an in-house curated T. brucei
database using the Mascot search engine v.2.2 (Matrix Science) run
on an in-house server using the following criteria: peptide
tolerance¼6p.p.m., trypsin as the enzyme and carboxyamido-
methylation of cysteine as a ﬁxed modiﬁcation. Variable modiﬁca-
tions were oxidation of methionine, N-acetylglucosamine
modiﬁcation of Asn and deamidation of Asn to Asp.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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